Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
QRSL1P2 is a pseudogene in humans, officially designated as "glutaminyl-tRNA synthase (glutamine-hydrolyzing)-like 1 pseudogene 2" and also referred to as QRSL1P2. Pseudogenes are genomic DNA sequences similar to known genes but are non-functional, usually due to mutations or lack of regulatory elements necessary for expression. QRSL1P2 is named for its homology to the functional gene QRSL1, which encodes a subunit of the mitochondrial glutaminyl-tRNA amidotransferase complex, but QRSL1P2 itself does not produce an active protein product and does not possess known biological, clinical, or pharmacological activity. Accordingly, it is not considered a valid therapeutic target, nor are there known disease associations, interacting drugs, biological processes, or molecular functions described for this pseudogene. QRSL1P2 is specifically listed as a pseudogene by authoritative sources including GeneCards and NCBI, with no evidence of protein-coding function or disease relevance. It is distinct from its protein-coding paralog QRSL1, which is involved in mitochondrial protein translation through the formation of correctly charged glutaminyl-tRNA(Gln), but this activity does not apply to the pseudogene. No information is available regarding QRSL1P2 as a therapeutic target, nor is it implicated in any pathway, disease, or as a drug target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glutaminyl-tRNA synthase (glutamine-hydrolyzing)-like 1 pseudogene 2 (QRSL1P2).